Similar articles

• Glucocorticoid therapy for severe Pneumocystis carinii pneumonia.

  Miller RF, Semple SJ. Miller RF, et al. J Infect. 1990 Sep;21(2):131-7. doi: 10.1016/0163-4453(90)91571-t. J Infect. 1990. PMID: 2230171 Review.
• Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.

  Mitsuyasu RT, Corwin HL, Harris AA, Trenholme GM, Levi S, Karkusis PH. Mitsuyasu RT, et al. Am Rev Respir Dis. 1982 Jun;125(6):762-5. doi: 10.1164/arrd.1982.125.6.762. Am Rev Respir Dis. 1982. PMID: 6979960
• Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.

  Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB. Medina I, et al. N Engl J Med. 1990 Sep 20;323(12):776-82. doi: 10.1056/NEJM199009203231202. N Engl J Med. 1990. PMID: 2392131 Clinical Trial.
• Chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.

  [No authors listed] [No authors listed] JAMA. 1988 Aug 19;260(7):921-2. JAMA. 1988. PMID: 3260965 No abstract available.
• Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.

  Morris-Jones SD, Easterbrook PJ. Morris-Jones SD, et al. J Antimicrob Chemother. 1997 Sep;40(3):315-8. doi: 10.1093/jac/40.3.315. J Antimicrob Chemother. 1997. PMID: 9338481 Review. No abstract available.